Prediction of chemo-response in serous ovarian cancer

BACKGROUND: Nearly one-third of serous ovarian cancer (OVCA) patients will not respond to initial treatment with surgery and chemotherapy and die within one year of diagnosis. If patients who are unlikely to respond to current standard therapy can be identified up front, enhanced tumor analyses and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez Bosquet, Jesus, Newtson, Andreea M., Chung, Rebecca K., Thiel, Kristina W., Ginader, Timothy, Goodheart, Michael J., Leslie, Kimberly K., Smith, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070116/
https://www.ncbi.nlm.nih.gov/pubmed/27756408
http://dx.doi.org/10.1186/s12943-016-0548-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070116/
https://www.ncbi.nlm.nih.gov/pubmed/27756408
http://dx.doi.org/10.1186/s12943-016-0548-9

Ejemplares similares